ACETAMINOPHEN AND CAFFEINE

ACETAMINOPHEN AND CAFFEINE was reported 10705 times

ACETAMINOPHEN AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA REFRACTORY 5 0.0769
1 URETERIC HAEMORRHAGE 5 0.0725
2 TESTICULAR OPERATION 4 0.0714
3 GRIP STRENGTH 16 0.0699
4 DENGUE HAEMORRHAGIC FEVER 3 0.0469
5 NASAL HERPES 8 0.0394
6 LUPUS VULGARIS 44 0.0349
7 HEPATIC ENZYME 5 0.0336
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 22 0.0329
9 HYPOAESTHESIA EYE 19 0.0322
10 ACTION TREMOR 5 0.0309
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 59 0.0295
12 FOETAL CHROMOSOME ABNORMALITY 5 0.0294
13 STEROID DEPENDENCE 23 0.0262
14 REDUCED FACIAL EXPRESSION 26 0.0256
15 FACET JOINT SYNDROME 82 0.0252
16 X-RAY ABNORMAL 45 0.0251
17 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 52 0.0251
18 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 14 0.0250
19 C-REACTIVE PROTEIN 23 0.0248
20 CATARRH 22 0.0243
21 SWOLLEN JOINT COUNT INCREASED 77 0.0241
22 SWOLLEN JOINT COUNT 6 0.0240
23 MULTIPLE DRUG THERAPY 18 0.0239
24 RHEUMATIC FEVER 106 0.0238
25 SCHIZOAFFECTIVE DISORDER 42 0.0235
26 CREATININE RENAL CLEARANCE INCREASED 15 0.0201
27 DUODENAL ULCER PERFORATION 149 0.0200
28 PERIPHERAL VENOUS DISEASE 81 0.0198
29 MERALGIA PARAESTHETICA 4 0.0190
30 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 130 0.0181
31 NEUROLOGIC NEGLECT SYNDROME 10 0.0180
32 DISLOCATION OF VERTEBRA 41 0.0180
33 RETINITIS 30 0.0174
34 HYPOCHOLESTEROLAEMIA 6 0.0170
35 MUSCLE INJURY 139 0.0168
36 TRANSFERRIN SATURATION DECREASED 7 0.0164
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 106 0.0163
38 FOLLICULITIS 171 0.0163
39 SINUS RHYTHM 7 0.0161
40 PORPHYRIA ACUTE 23 0.0160
41 NIPPLE SWELLING 4 0.0159
42 HELICOBACTER INFECTION 160 0.0156
43 RHEUMATOID FACTOR POSITIVE 89 0.0154
44 C-REACTIVE PROTEIN ABNORMAL 92 0.0143
45 MEAN PLATELET VOLUME DECREASED 12 0.0143
46 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
47 ABDOMINAL LYMPHADENOPATHY 12 0.0138
48 PEMPHIGUS 172 0.0137
49 AUTOIMMUNE NEPHRITIS 3 0.0136
50 NEUTROPENIC INFECTION 13 0.0136
51 ANTIPSYCHOTIC DRUG LEVEL DECREASED 7 0.0132
52 HAND DEFORMITY 168 0.0128
53 BLISTER INFECTED 10 0.0128
54 BURNS SECOND DEGREE 22 0.0125
55 MONOCYTE COUNT DECREASED 15 0.0123
56 C-REACTIVE PROTEIN DECREASED 8 0.0123
57 SEDATION COMPLICATION 31 0.0121
58 CAROTID ARTERY THROMBOSIS 10 0.0118
59 PERICARDITIS 175 0.0104
60 IMMUNODEFICIENCY COMMON VARIABLE 5 0.0102
61 BONE EROSION 36 0.0102
62 LISTLESS 33 0.0100
63 BREAST CANCER STAGE III 64 0.0099
64 LIP DRY 84 0.0092
65 HYPERCHOLESTEROLAEMIA 89 0.0092
66 SYNOVITIS 166 0.0092
67 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
68 ONYCHOMADESIS 37 0.0088
69 ALCOHOL POISONING 23 0.0086
70 ONYCHOMYCOSIS 37 0.0084
71 CREATININE RENAL CLEARANCE DECREASED 33 0.0082
72 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
73 BURSITIS 95 0.0078
74 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 13 0.0078
75 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 5 0.0078
76 ADJUSTMENT DISORDER 10 0.0077
77 JOINT RANGE OF MOTION DECREASED 102 0.0076
78 GLOSSODYNIA 168 0.0075
79 VESTIBULAR NEURONITIS 4 0.0075
80 GRIP STRENGTH DECREASED 65 0.0074
81 IRRITABLE BOWEL SYNDROME 157 0.0073
82 LIVE BIRTH 59 0.0070
83 WOUND INFECTION 72 0.0066
84 HYPOPNOEA 22 0.0063
85 WOUND 171 0.0061
86 ARTERIOVENOUS FISTULA 3 0.0061
87 AUTOIMMUNE DISORDER 58 0.0059
88 STREPTOCOCCAL SEPSIS 7 0.0059
89 SYSTEMIC LUPUS ERYTHEMATOSUS 208 0.0059
90 FACIAL DISCOMFORT 4 0.0056
91 IMPAIRED HEALING 179 0.0054
92 CHIKUNGUNYA VIRUS INFECTION 3 0.0054
93 MATERNAL EXPOSURE TIMING UNSPECIFIED 20 0.0053
94 SERONEGATIVE ARTHRITIS 6 0.0052
95 RENAL FUNCTION TEST ABNORMAL 24 0.0052
96 OBESITY 78 0.0049
97 IMMOBILE 21 0.0048
98 RED BLOOD CELL SEDIMENTATION RATE INCREASED 53 0.0048
99 PRODUCT USED FOR UNKNOWN INDICATION 6 0.0048
100 LIVER INJURY 117 0.0048
101 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
102 FIBROMYALGIA 115 0.0047
103 MEDICATION OVERUSE HEADACHE 4 0.0047
104 WALKING AID USER 30 0.0045
105 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
106 FOREIGN BODY 18 0.0045
107 FACIAL SPASM 5 0.0045
108 LOWER RESPIRATORY TRACT INFECTION 203 0.0045
109 PRODUCT LABEL CONFUSION 26 0.0045
110 SCIATICA 71 0.0044
111 BLEPHAROSPASM 28 0.0044
112 VULVOVAGINAL CANDIDIASIS 6 0.0044
113 TYPE 2 DIABETES MELLITUS 144 0.0043
114 EXOSTOSIS 39 0.0043
115 FINGER DEFORMITY 20 0.0041
116 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
117 BRAIN STEM SYNDROME 3 0.0040
118 NAIL DISORDER 35 0.0040
119 PERIARTHRITIS 9 0.0040
120 TROPONIN T INCREASED 5 0.0039
121 PARAINFLUENZAE VIRUS INFECTION 6 0.0039
122 EYE COLOUR CHANGE 4 0.0039
123 PERSONALITY DISORDER 10 0.0038
124 SYSTOLIC DYSFUNCTION 4 0.0038
125 TUMOUR PAIN 5 0.0038
126 PUSTULAR PSORIASIS 13 0.0038
127 VITREOUS DETACHMENT 8 0.0037
128 URETERIC OBSTRUCTION 5 0.0037
129 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
130 METABOLIC SYNDROME 6 0.0036
131 AFFECT LABILITY 35 0.0036
132 DRUG TOLERANCE DECREASED 10 0.0036
133 LOWER LIMB FRACTURE 68 0.0035
134 RASH VESICULAR 17 0.0035
135 PRESCRIBED OVERDOSE 68 0.0035
136 PSORIATIC ARTHROPATHY 142 0.0035
137 PELVIC FRACTURE 27 0.0035
138 BRONCHIECTASIS 23 0.0034
139 LIVER FUNCTION TEST INCREASED 73 0.0034
140 LUPUS-LIKE SYNDROME 30 0.0033
141 EYE INJURY 10 0.0033
142 BLOOD CALCIUM DECREASED 37 0.0033
143 CONTRAINDICATED PRODUCT ADMINISTERED 98 0.0032
144 FRACTURED SACRUM 4 0.0032
145 PAROSMIA 24 0.0032
146 TESTICULAR SWELLING 4 0.0032
147 RHINITIS 25 0.0031
148 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
149 STOMA SITE INFECTION 4 0.0031
150 COELIAC DISEASE 30 0.0031
151 C-REACTIVE PROTEIN INCREASED 111 0.0030
152 PULMONARY FIBROSIS 58 0.0030
153 GINGIVAL PAIN 24 0.0030
154 DELIRIUM 104 0.0030
155 INFUSION RELATED REACTION 197 0.0030
156 NIGHT SWEATS 95 0.0029
157 GAIT INABILITY 97 0.0029
158 HYPOPITUITARISM 5 0.0029
159 JOINT DISLOCATION 30 0.0028
160 HYPERKINESIA 6 0.0028
161 MOBILITY DECREASED 202 0.0028
162 ARTHROPATHY 156 0.0028
163 BLOOD CHOLESTEROL INCREASED 130 0.0028
164 CARDIAC MURMUR 24 0.0028
165 BREAST CANCER STAGE II 23 0.0028
166 BLISTER 155 0.0028
167 NORMAL NEWBORN 15 0.0028
168 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
169 MUSCLE SPASTICITY 33 0.0027
170 OSTEOARTHRITIS 113 0.0027
171 HEPATIC ENZYME INCREASED 180 0.0026
172 SEDATION 69 0.0026
173 FOOT DEFORMITY 29 0.0026
174 APATHY 38 0.0026
175 DRUG LEVEL INCREASED 43 0.0026
176 MYOSITIS 23 0.0026
177 DISCOMFORT 153 0.0025
178 BACK INJURY 27 0.0025
179 SPONDYLITIS 9 0.0025
180 VASOPLEGIA SYNDROME 4 0.0024
181 HYPERPARATHYROIDISM 5 0.0024
182 ILL-DEFINED DISORDER 146 0.0024
183 STOMATITIS 144 0.0024
184 BAND SENSATION 3 0.0024
185 ULCER HAEMORRHAGE 16 0.0024
186 HEPATIC CIRRHOSIS 44 0.0023
187 SERUM FERRITIN DECREASED 4 0.0023
188 HEMIPLEGIA 19 0.0023
189 CUSHINGOID 7 0.0022
190 CALCIPHYLAXIS 4 0.0022
191 STOMA SITE ERYTHEMA 4 0.0021
192 CHRONIC SINUSITIS 8 0.0021
193 ALVEOLITIS 3 0.0021
194 OROPHARYNGEAL DISCOMFORT 19 0.0021
195 PREGNANCY 42 0.0021
196 SCHIZOPHRENIA 25 0.0021
197 THERAPEUTIC PRODUCT EFFECT DECREASED 92 0.0021
198 SWELLING 192 0.0020
199 LIVER DISORDER 90 0.0020
200 INJURY 142 0.0020
201 SLEEP DISORDER 141 0.0020
202 GANGRENE 12 0.0020
203 HEAD DISCOMFORT 35 0.0020
204 IMMUNE-MEDIATED HEPATITIS 4 0.0020
205 ORTHOSTATIC HYPOTENSION 34 0.0020
206 WHEEZING 115 0.0019
207 MUSCULOSKELETAL PAIN 101 0.0019
208 GENERAL PHYSICAL HEALTH DETERIORATION 222 0.0019
209 INFLAMMATION 99 0.0019
210 BLADDER DISORDER 19 0.0019
211 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
212 OEDEMA 102 0.0019
213 NIGHTMARE 65 0.0019
214 IMMUNODEFICIENCY 28 0.0019
215 ABSCESS INTESTINAL 4 0.0019
216 STOMA SITE DISCHARGE 5 0.0018
217 FREQUENT BOWEL MOVEMENTS 49 0.0018
218 CONFUSIONAL STATE 293 0.0018
219 CONTUSION 174 0.0018
220 EAR PAIN 35 0.0018
221 FAECES PALE 4 0.0018
222 SPINAL CORD COMPRESSION 7 0.0018
223 GASTROINTESTINAL DISORDER 159 0.0018
224 ROAD TRAFFIC ACCIDENT 74 0.0018
225 HIP ARTHROPLASTY 27 0.0018
226 PRESCRIBED UNDERDOSE 35 0.0018
227 LUNG DISORDER 85 0.0017
228 RHEUMATOID ARTHRITIS 194 0.0017
229 JOINT SWELLING 204 0.0017
230 MUSCULOSKELETAL STIFFNESS 147 0.0017
231 INFUSION SITE REACTION 5 0.0017
232 CEREBROVASCULAR DISORDER 5 0.0017
233 BONE MARROW DISORDER 5 0.0017
234 SINUSITIS 169 0.0016
235 UTERINE LEIOMYOMA 12 0.0016
236 TASTE DISORDER 33 0.0016
237 RETROPERITONEAL HAEMORRHAGE 4 0.0016
238 SENSORY LOSS 13 0.0016
239 KNEE ARTHROPLASTY 34 0.0016
240 INFLAMMATORY MARKER INCREASED 8 0.0016
241 COGNITIVE DISORDER 75 0.0016
242 BLOOD IRON DECREASED 19 0.0016
243 GENERAL SYMPTOM 12 0.0016
244 IMPAIRED QUALITY OF LIFE 23 0.0016
245 SQUAMOUS CELL CARCINOMA 15 0.0016
246 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 76 0.0016
247 MOTOR DYSFUNCTION 16 0.0016
248 MEDICATION ERROR 87 0.0016
249 DRY MOUTH 126 0.0016
250 ABDOMINAL WALL HAEMATOMA 3 0.0015
251 URINARY RETENTION 51 0.0015
252 VITAMIN D DECREASED 13 0.0015
253 CEREBRAL ATROPHY 6 0.0015
254 POOR QUALITY SLEEP 32 0.0015
255 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
256 NEUTROPHIL COUNT INCREASED 15 0.0015
257 LEFT VENTRICULAR FAILURE 5 0.0015
258 BEDRIDDEN 19 0.0014
259 ADVERSE REACTION 19 0.0014
260 PROCTITIS 4 0.0014
261 MATERNAL EXPOSURE DURING PREGNANCY 127 0.0014
262 UROSEPSIS 13 0.0014
263 CARDIAC FAILURE CHRONIC 6 0.0014
264 ABSCESS LIMB 6 0.0014
265 FIBRIN D DIMER INCREASED 5 0.0014
266 DRUG-INDUCED LIVER INJURY 44 0.0014
267 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
268 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
269 PYODERMA GANGRENOSUM 5 0.0014
270 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
271 INTENTIONAL PRODUCT USE ISSUE 121 0.0014
272 CLOSTRIDIUM TEST POSITIVE 3 0.0014
273 THORACIC VERTEBRAL FRACTURE 4 0.0014
274 FREEZING PHENOMENON 5 0.0013
275 RECTAL HAEMORRHAGE 58 0.0013
276 PERIORBITAL OEDEMA 7 0.0013
277 VERTIGO 82 0.0013
278 JOINT STIFFNESS 35 0.0013
279 HEPATIC NECROSIS 5 0.0013
280 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
281 BODY TEMPERATURE INCREASED 27 0.0013
282 TROPONIN INCREASED 10 0.0013
283 DENGUE FEVER 3 0.0013
284 LIVER FUNCTION TEST ABNORMAL 38 0.0013
285 CLAVICLE FRACTURE 5 0.0013
286 LOCALISED OEDEMA 6 0.0013
287 FOOD ALLERGY 10 0.0013
288 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
289 RHINOVIRUS INFECTION 5 0.0013
290 BLOOD CREATININE DECREASED 4 0.0013
291 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
292 INFECTION 184 0.0013
293 RESPIRATORY DISORDER 38 0.0013
294 TESTICULAR PAIN 4 0.0013
295 NEUTROPENIC SEPSIS 9 0.0013
296 POLYMYALGIA RHEUMATICA 4 0.0013
297 LYMPHOCYTE COUNT DECREASED 22 0.0012
298 HAEMOGLOBIN ABNORMAL 8 0.0012
299 EXPOSURE DURING PREGNANCY 77 0.0012
300 SPINAL FUSION SURGERY 5 0.0012
301 NEUROLOGICAL SYMPTOM 7 0.0012
302 ANAL INCONTINENCE 11 0.0012
303 DERMAL CYST 3 0.0012
304 MYOCARDITIS 14 0.0012
305 HEPATITIS 31 0.0012
306 OTITIS MEDIA 4 0.0012
307 EAR INFECTION 32 0.0012
308 CONGESTIVE CARDIOMYOPATHY 5 0.0012
309 ABDOMINAL DISCOMFORT 200 0.0012
310 DRUG INTOLERANCE 115 0.0012
311 HYPERTENSION 252 0.0012
312 BRADYKINESIA 7 0.0012
313 HEPATIC CYST 4 0.0012
314 PNEUMONITIS 32 0.0012
315 HYPERSENSITIVITY 218 0.0012
316 CANCER PAIN 3 0.0012
317 MIGRAINE 112 0.0012
318 FACIAL PARALYSIS 10 0.0012
319 FEMORAL NECK FRACTURE 6 0.0012
320 PERIPHERAL SWELLING 179 0.0012
321 PLATELET COUNT INCREASED 15 0.0011
322 COMPARTMENT SYNDROME 3 0.0011
323 HYPOAESTHESIA 172 0.0011
324 ENCEPHALOPATHY 28 0.0011
325 POLYARTHRITIS 6 0.0011
326 JAUNDICE CHOLESTATIC 4 0.0011
327 COLITIS ULCERATIVE 50 0.0011
328 OVERWEIGHT 6 0.0011
329 SPLENOMEGALY 13 0.0011
330 BACK DISORDER 18 0.0011
331 TREATMENT FAILURE 91 0.0011
332 EPILEPSY 33 0.0011
333 PYREXIA 373 0.0011
334 PERFORMANCE STATUS DECREASED 5 0.0011
335 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
336 DISABILITY 21 0.0011
337 NASOPHARYNGITIS 195 0.0011
338 FRACTURE 20 0.0011
339 THERAPY NON-RESPONDER 47 0.0010
340 BLOOD URIC ACID INCREASED 6 0.0010
341 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
342 DEPRESSED LEVEL OF CONSCIOUSNESS 41 0.0010
343 COMA SCALE ABNORMAL 3 0.0010
344 THROAT TIGHTNESS 28 0.0010
345 CONGENITAL ANOMALY 8 0.0010
346 RALES 6 0.0010
347 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
348 HYPONATRAEMIA 58 0.0010
349 RESTLESSNESS 37 0.0010
350 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
351 INJECTION SITE INFLAMMATION 5 0.0010
352 HAEMOGLOBIN DECREASED 103 0.0010
353 NECK PAIN 56 0.0010
354 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0010
355 HYPERAMMONAEMIA 5 0.0010
356 BLEPHARITIS 4 0.0010
357 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
358 AMNESIA 64 0.0010
359 IRON DEFICIENCY ANAEMIA 9 0.0010
360 SELF-MEDICATION 4 0.0010
361 CHOLANGITIS 6 0.0010
362 FOETAL DEATH 5 0.0010
363 SWOLLEN TONGUE 30 0.0010
364 BLOOD BLISTER 3 0.0010
365 HAEMATOCRIT DECREASED 19 0.0010
366 PALLOR 26 0.0010
367 URTICARIA 159 0.0009
368 SKIN HAEMORRHAGE 14 0.0009
369 HEMIPARESIS 16 0.0009
370 RED BLOOD CELL COUNT DECREASED 27 0.0009
371 RESPIRATORY TRACT CONGESTION 15 0.0009
372 OXYGEN SATURATION DECREASED 53 0.0009
373 ARTHRITIS 73 0.0009
374 STRESS FRACTURE 5 0.0009
375 OEDEMA PERIPHERAL 112 0.0009
376 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
377 MUSCULAR WEAKNESS 104 0.0009
378 BOWEL MOVEMENT IRREGULARITY 7 0.0009
379 ORAL CANDIDIASIS 12 0.0009
380 INTESTINAL ISCHAEMIA 5 0.0009
381 PARAESTHESIA ORAL 13 0.0009
382 OSTEOPOROSIS 37 0.0009
383 CYTOKINE RELEASE SYNDROME 18 0.0009
384 EMPHYSEMA 9 0.0009
385 IRON DEFICIENCY 4 0.0009
386 POSTOPERATIVE WOUND INFECTION 6 0.0009
387 HYPOKALAEMIA 41 0.0009
388 SINUS CONGESTION 12 0.0009
389 ALOPECIA 174 0.0009
390 DYSPEPSIA 87 0.0009
391 HERNIA 17 0.0009
392 NEUTROPHILIA 5 0.0009
393 EYE MOVEMENT DISORDER 6 0.0009
394 ECCHYMOSIS 6 0.0009
395 IMMUNE THROMBOCYTOPENIA 4 0.0009
396 LUMBAR VERTEBRAL FRACTURE 4 0.0009
397 ANGINA PECTORIS 25 0.0009
398 BLOOD CREATININE ABNORMAL 3 0.0009
399 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
400 AORTIC STENOSIS 3 0.0009
401 METABOLIC DISORDER 5 0.0009
402 COORDINATION ABNORMAL 12 0.0009
403 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
404 FEBRILE NEUTROPENIA 57 0.0009
405 DEMENTIA 24 0.0009
406 HYPOVOLAEMIA 5 0.0009
407 PREGNANCY WITH IMPLANT CONTRACEPTIVE 4 0.0009
408 INCONTINENCE 9 0.0009
409 WEIGHT INCREASED 189 0.0008
410 IMPAIRED WORK ABILITY 18 0.0008
411 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
412 BREAST CANCER METASTATIC 9 0.0008
413 TUMOUR MARKER INCREASED 4 0.0008
414 INGUINAL HERNIA 5 0.0008
415 BALANCE DISORDER 71 0.0008
416 ACCIDENTAL OVERDOSE 30 0.0008
417 ORAL HERPES 16 0.0008
418 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
419 DECREASED APPETITE 189 0.0008
420 DRUG INTERACTION 129 0.0008
421 AMYLASE INCREASED 3 0.0008
422 ALCOHOL USE 3 0.0008
423 MYOPATHY 7 0.0008
424 FOOT OPERATION 4 0.0008
425 CHEST PAIN 149 0.0008
426 HEPATIC ENZYME ABNORMAL 4 0.0008
427 ABDOMINAL PAIN UPPER 164 0.0008
428 ASTHMA 90 0.0008
429 ERYSIPELAS 4 0.0008
430 CORONARY ARTERY STENOSIS 4 0.0008
431 VULVOVAGINAL PRURITUS 4 0.0008
432 PAIN IN EXTREMITY 229 0.0008
433 MUSCULOSKELETAL CHEST PAIN 12 0.0008
434 SKIN NECROSIS 4 0.0008
435 SPINAL PAIN 9 0.0008
436 TONSILLITIS 4 0.0008
437 LETHARGY 44 0.0008
438 WEIGHT FLUCTUATION 8 0.0008
439 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
440 HYPOGAMMAGLOBULINAEMIA 5 0.0008
441 HYPERTHYROIDISM 11 0.0008
442 NERVE COMPRESSION 7 0.0008
443 SERUM FERRITIN INCREASED 4 0.0008
444 PANCREATITIS 40 0.0008
445 SKIN MASS 5 0.0007
446 MALIGNANT MELANOMA 10 0.0007
447 POST-TRAUMATIC STRESS DISORDER 5 0.0007
448 HEREDITARY ANGIOEDEMA 8 0.0007
449 HAEMATOCHEZIA 41 0.0007
450 ASPHYXIA 6 0.0007
451 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
452 ARTHRITIS BACTERIAL 3 0.0007
453 RESPIRATORY TRACT INFECTION 19 0.0007
454 ESCHERICHIA INFECTION 6 0.0007
455 ACUTE CORONARY SYNDROME 6 0.0007
456 CONDITION AGGRAVATED 220 0.0007
457 DIVERTICULITIS 20 0.0007
458 GASTROOESOPHAGEAL REFLUX DISEASE 58 0.0007
459 HAEMORRHOIDS 14 0.0007
460 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
461 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
462 URINARY INCONTINENCE 21 0.0007
463 SINUS DISORDER 14 0.0007
464 PARAESTHESIA 111 0.0007
465 PERONEAL NERVE PALSY 4 0.0007
466 NEURALGIA 17 0.0007
467 APHASIA 21 0.0007
468 HAEMATOMA 18 0.0007
469 MOUTH SWELLING 4 0.0007
470 VAGINAL DISCHARGE 7 0.0007
471 ATRIAL FIBRILLATION 67 0.0007
472 GASTROENTERITIS 10 0.0007
473 PRODUCT USE IN UNAPPROVED INDICATION 169 0.0007
474 RIB FRACTURE 14 0.0007
475 FALL 225 0.0007
476 METASTASES TO BONE 11 0.0007
477 PAIN 409 0.0007
478 MOUTH ULCERATION 14 0.0007
479 DYSARTHRIA 25 0.0007
480 HYPERHIDROSIS 85 0.0007
481 PRODUCT USE ISSUE 124 0.0007
482 EATING DISORDER 14 0.0007
483 INSOMNIA 175 0.0007
484 TINNITUS 30 0.0007
485 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
486 GAIT DISTURBANCE 124 0.0006
487 ARTHRALGIA 269 0.0006
488 RASH 282 0.0006
489 ARTHRITIS INFECTIVE 3 0.0006
490 LIMB DISCOMFORT 20 0.0006
491 PHARYNGITIS 8 0.0006
492 HEPATIC STEATOSIS 12 0.0006
493 APPENDICITIS 6 0.0006
494 PHOTOPHOBIA 12 0.0006
495 FEELING HOT 39 0.0006
496 ANXIETY 180 0.0006
497 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
498 BLOOD ALBUMIN DECREASED 5 0.0006
499 HEPATIC FAILURE 19 0.0006
500 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
501 SUICIDE ATTEMPT 38 0.0006
502 ATELECTASIS 6 0.0006
503 DIPLOPIA 16 0.0006
504 HEPATITIS ACUTE 4 0.0006
505 CHOKING 12 0.0006
506 DYSPNOEA 348 0.0006
507 TENDON DISORDER 4 0.0006
508 HAEMATURIA 21 0.0006
509 PNEUMONIA 198 0.0006
510 MEMORY IMPAIRMENT 84 0.0006
511 NEPHROLITHIASIS 28 0.0006
512 MUSCLE SPASMS 112 0.0006
513 COLITIS 23 0.0006
514 ABDOMINAL PAIN 141 0.0006
515 ABDOMINAL TENDERNESS 3 0.0006
516 HYPOACUSIS 26 0.0006
517 HYPOTENSION 121 0.0006
518 VOMITING 283 0.0006
519 SPINAL FRACTURE 12 0.0006
520 DYSURIA 22 0.0006
521 CHILLS 70 0.0006
522 MOOD SWINGS 19 0.0006
523 INTENTIONAL PRODUCT MISUSE 52 0.0006
524 DEPRESSION 135 0.0006
525 INFUSION SITE ERYTHEMA 5 0.0006
526 METASTASES TO LYMPH NODES 4 0.0006
527 MOVEMENT DISORDER 19 0.0006
528 MALAISE 257 0.0006
529 HYPERLIPIDAEMIA 7 0.0006
530 TACHYCARDIA 52 0.0006
531 TEMPERATURE INTOLERANCE 6 0.0006
532 HYPOCALCAEMIA 11 0.0006
533 BONE PAIN 34 0.0006
534 RESPIRATION ABNORMAL 4 0.0006
535 SNEEZING 13 0.0006
536 TOOTH LOSS 12 0.0006
537 GASTRIC ULCER 11 0.0006
538 MUSCLE STRAIN 5 0.0006
539 VENTRICULAR EXTRASYSTOLES 6 0.0006
540 INTENTIONAL OVERDOSE 37 0.0006
541 ACUTE MYOCARDIAL INFARCTION 17 0.0006
542 CHROMATURIA 13 0.0006
543 TENDERNESS 6 0.0006
544 APLASTIC ANAEMIA 3 0.0006
545 HEADACHE 359 0.0006
546 THROMBOCYTOPENIA 64 0.0006
547 PALPITATIONS 67 0.0006
548 RESPIRATORY DEPRESSION 7 0.0006
549 BLOOD CALCIUM INCREASED 5 0.0006
550 GROIN PAIN 5 0.0006
551 SPINAL OSTEOARTHRITIS 5 0.0006
552 HYPERCALCAEMIA 7 0.0006
553 LYMPHOPENIA 8 0.0006
554 SENSORY DISTURBANCE 9 0.0006
555 FACIAL PAIN 5 0.0006
556 PULMONARY OEDEMA 25 0.0006
557 PULMONARY EMBOLISM 53 0.0006
558 ECZEMA 29 0.0006
559 DEEP VEIN THROMBOSIS 36 0.0006
560 DERMATITIS BULLOUS 4 0.0006
561 TOOTHACHE 10 0.0006
562 INJECTION SITE REACTION 38 0.0006
563 OPTIC NEURITIS 5 0.0005
564 CONSTIPATION 120 0.0005
565 BLOOD GLUCOSE FLUCTUATION 6 0.0005
566 DEHYDRATION 73 0.0005
567 BACK PAIN 127 0.0005
568 ABDOMINAL DISTENSION 57 0.0005
569 AUTISM SPECTRUM DISORDER 3 0.0005
570 NERVOUS SYSTEM DISORDER 17 0.0005
571 ASCITES 16 0.0005
572 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
573 OVARIAN CANCER 5 0.0005
574 LABORATORY TEST ABNORMAL 16 0.0005
575 CARDIOMYOPATHY 8 0.0005
576 NERVE INJURY 6 0.0005
577 FEELING COLD 15 0.0005
578 MENTAL IMPAIRMENT 13 0.0005
579 CELLULITIS 27 0.0005
580 ADVERSE DRUG REACTION 48 0.0005
581 CYSTITIS 17 0.0005
582 SPINAL DISORDER 5 0.0005
583 CHEST DISCOMFORT 54 0.0005
584 FATIGUE 408 0.0005
585 ASTHENIA 197 0.0005
586 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
587 LIPASE INCREASED 4 0.0005
588 NEOPLASM 6 0.0005
589 SINUS BRADYCARDIA 5 0.0005
590 FEMUR FRACTURE 16 0.0005
591 ELECTROLYTE IMBALANCE 6 0.0005
592 RETCHING 11 0.0005
593 LUNG INFECTION 8 0.0005
594 ACUTE MYELOID LEUKAEMIA 8 0.0005
595 BASAL CELL CARCINOMA 8 0.0005
596 VITAMIN D DEFICIENCY 5 0.0005
597 PHARYNGEAL SWELLING 5 0.0005
598 GASTROINTESTINAL INFLAMMATION 4 0.0005
599 AFFECTIVE DISORDER 4 0.0005
600 HEPATOMEGALY 5 0.0005
601 RENAL CYST 4 0.0005
602 TRICUSPID VALVE INCOMPETENCE 4 0.0005
603 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
604 SKIN ULCER 13 0.0005
605 GOUT 9 0.0005
606 BLOOD DISORDER 4 0.0005
607 BLOOD TEST ABNORMAL 7 0.0005
608 DYSGEUSIA 37 0.0005
609 DEVICE OCCLUSION 7 0.0005
610 MYASTHENIA GRAVIS 4 0.0005
611 PRURITUS 190 0.0005
612 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
613 POST PROCEDURAL INFECTION 4 0.0005
614 SUBARACHNOID HAEMORRHAGE 5 0.0005
615 CYTOPENIA 6 0.0005
616 ABNORMAL FAECES 4 0.0005
617 RASH MACULAR 17 0.0005
618 PHOTOSENSITIVITY REACTION 8 0.0005
619 MYELODYSPLASTIC SYNDROME 7 0.0005
620 SPINAL COMPRESSION FRACTURE 4 0.0005
621 URINARY TRACT INFECTION 82 0.0005
622 DRUG ABUSE 40 0.0005
623 SYNCOPE 48 0.0005
624 PETECHIAE 5 0.0005
625 UNINTENDED PREGNANCY 5 0.0005
626 NAUSEA 378 0.0005
627 BLOOD URINE PRESENT 9 0.0005
628 WEIGHT DECREASED 132 0.0005
629 FLUID RETENTION 24 0.0005
630 RENAL PAIN 5 0.0005
631 SLEEP APNOEA SYNDROME 9 0.0005
632 JOINT INJURY 10 0.0005
633 HYPERGLYCAEMIA 17 0.0005
634 ARRHYTHMIA 22 0.0005
635 RHINORRHOEA 30 0.0005
636 BLOOD MAGNESIUM DECREASED 4 0.0005
637 PYELONEPHRITIS 4 0.0005
638 DIZZINESS 229 0.0005
639 DEAFNESS 12 0.0005
640 URINE OUTPUT DECREASED 4 0.0005
641 SKIN DISCOLOURATION 21 0.0005
642 TUMOUR LYSIS SYNDROME 4 0.0005
643 SARS-COV-2 TEST POSITIVE 6 0.0005
644 HYPERSOMNIA 13 0.0005
645 IMMUNOSUPPRESSION 4 0.0005
646 PURPURA 4 0.0005
647 ABORTION SPONTANEOUS 18 0.0004
648 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
649 THIRST 8 0.0004
650 HAEMOLYTIC ANAEMIA 4 0.0004
651 FEEDING DISORDER 9 0.0004
652 DYSKINESIA 18 0.0004
653 PELVIC PAIN 8 0.0004
654 SKIN LESION 12 0.0004
655 CATARACT 26 0.0004
656 ABDOMINAL PAIN LOWER 11 0.0004
657 MUSCLE TIGHTNESS 7 0.0004
658 HYPERKALAEMIA 15 0.0004
659 DIARRHOEA 276 0.0004
660 CHOLELITHIASIS 14 0.0004
661 FLANK PAIN 4 0.0004
662 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
663 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
664 SINUS TACHYCARDIA 6 0.0004
665 BRONCHOSPASM 6 0.0004
666 CHOLECYSTITIS 5 0.0004
667 BLOOD PRESSURE INCREASED 64 0.0004
668 WRIST FRACTURE 5 0.0004
669 FLUID OVERLOAD 6 0.0004
670 CIRCULATORY COLLAPSE 7 0.0004
671 PARKINSONISM 4 0.0004
672 CEREBRAL INFARCTION 10 0.0004
673 MELAENA 9 0.0004
674 MUSCULOSKELETAL DISCOMFORT 7 0.0004
675 TENDON RUPTURE 5 0.0004
676 RASH MACULO-PAPULAR 9 0.0004
677 LIGAMENT SPRAIN 4 0.0004
678 ANAEMIA 77 0.0004
679 PULMONARY MASS 6 0.0004
680 ILEUS 5 0.0004
681 TOOTH EXTRACTION 5 0.0004
682 RASH PAPULAR 9 0.0004
683 SECRETION DISCHARGE 5 0.0004
684 PSORIASIS 52 0.0004
685 HALLUCINATION 30 0.0004
686 MULTIPLE SCLEROSIS 19 0.0004
687 COLD SWEAT 7 0.0004
688 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
689 DRUG ERUPTION 7 0.0004
690 TOOTH ABSCESS 4 0.0004
691 DRUG DISPENSING ERROR 6 0.0004
692 ACIDOSIS 3 0.0004
693 ADVERSE EVENT 36 0.0004
694 MUSCLE TWITCHING 9 0.0004
695 NEUTROPENIA 53 0.0004
696 CEREBROVASCULAR ACCIDENT 66 0.0004
697 OROPHARYNGEAL PAIN 36 0.0004
698 INFLUENZA LIKE ILLNESS 32 0.0004
699 PAIN IN JAW 11 0.0004
700 TENDONITIS 6 0.0004
701 DELUSION 6 0.0004
702 EJECTION FRACTION DECREASED 6 0.0004
703 SEPSIS 43 0.0004
704 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
705 SOMNOLENCE 77 0.0004
706 TRANSFUSION 4 0.0004
707 CYANOSIS 6 0.0004
708 ANAPHYLACTIC REACTION 21 0.0004
709 IMMUNE SYSTEM DISORDER 5 0.0004
710 DYSPHAGIA 36 0.0004
711 HEAD INJURY 12 0.0004
712 PRODUCT PRESCRIBING ERROR 9 0.0004
713 OFF LABEL USE 329 0.0004
714 BODY HEIGHT DECREASED 4 0.0004
715 VISUAL IMPAIRMENT 46 0.0004
716 LIMB INJURY 10 0.0004
717 DECUBITUS ULCER 3 0.0004
718 TACHYPNOEA 5 0.0004
719 BRONCHITIS 27 0.0004
720 POST PROCEDURAL COMPLICATION 7 0.0004
721 ACUTE RESPIRATORY FAILURE 7 0.0004
722 CORONARY ARTERY DISEASE 11 0.0004
723 OVERDOSE 78 0.0004
724 ORAL DISCOMFORT 5 0.0004
725 AGGRESSION 18 0.0004
726 HYPERTENSIVE CRISIS 4 0.0004
727 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
728 INFLUENZA 40 0.0004
729 KIDNEY INFECTION 7 0.0004
730 SKIN INFECTION 4 0.0004
731 PRODUCTIVE COUGH 17 0.0004
732 RASH ERYTHEMATOUS 17 0.0004
733 HAEMATEMESIS 9 0.0004
734 HEART RATE IRREGULAR 8 0.0004
735 MITRAL VALVE INCOMPETENCE 4 0.0004
736 BLOOD PRESSURE ABNORMAL 7 0.0004
737 HYPOPHAGIA 9 0.0004
738 MYOCARDIAL ISCHAEMIA 4 0.0004
739 PRODUCT AVAILABILITY ISSUE 8 0.0004
740 METASTASES TO LUNG 4 0.0003
741 PLEURAL EFFUSION 21 0.0003
742 SEPTIC SHOCK 15 0.0003
743 HYPOXIA 12 0.0003
744 DRY EYE 17 0.0003
745 DEPRESSED MOOD 18 0.0003
746 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
747 COVID-19 PNEUMONIA 4 0.0003
748 PLATELET COUNT DECREASED 36 0.0003
749 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
750 ATAXIA 4 0.0003
751 PULMONARY HYPERTENSION 7 0.0003
752 POLLAKIURIA 14 0.0003
753 COUGH 94 0.0003
754 MACULAR DEGENERATION 4 0.0003
755 RENAL IMPAIRMENT 28 0.0003
756 HYPOAESTHESIA ORAL 5 0.0003
757 COVID-19 58 0.0003
758 VIRAL INFECTION 11 0.0003
759 HYPOGLYCAEMIA 16 0.0003
760 NOCTURIA 4 0.0003
761 BONE DISORDER 6 0.0003
762 SKIN CANCER 7 0.0003
763 PHARYNGEAL OEDEMA 5 0.0003
764 SMALL INTESTINAL OBSTRUCTION 4 0.0003
765 DEVICE RELATED INFECTION 5 0.0003
766 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
767 HEART RATE INCREASED 32 0.0003
768 HAIR COLOUR CHANGES 4 0.0003
769 DEFORMITY 3 0.0003
770 PNEUMONIA ASPIRATION 8 0.0003
771 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
772 NEUTROPHIL COUNT DECREASED 13 0.0003
773 PRODUCT USE COMPLAINT 5 0.0003
774 ANGIOEDEMA 14 0.0003
775 STEVENS-JOHNSON SYNDROME 7 0.0003
776 ULCER 5 0.0003
777 BURNING SENSATION 22 0.0003
778 WHITE BLOOD CELL COUNT DECREASED 34 0.0003
779 HYPOTHYROIDISM 10 0.0003
780 HIP FRACTURE 10 0.0003
781 HIATUS HERNIA 4 0.0003
782 BLOOD POTASSIUM INCREASED 5 0.0003
783 MYALGIA 52 0.0003
784 ANKYLOSING SPONDYLITIS 4 0.0003
785 ABNORMAL BEHAVIOUR 12 0.0003
786 LEUKOPENIA 15 0.0003
787 BRAIN INJURY 3 0.0003
788 BLOOD UREA INCREASED 5 0.0003
789 QUALITY OF LIFE DECREASED 4 0.0003
790 JAUNDICE 8 0.0003
791 LOSS OF CONSCIOUSNESS 38 0.0003
792 CANDIDA INFECTION 5 0.0003
793 UVEITIS 4 0.0003
794 EPISTAXIS 22 0.0003
795 DYSPNOEA EXERTIONAL 11 0.0003
796 MULTIPLE SCLEROSIS RELAPSE 20 0.0003
797 DYSPHONIA 17 0.0003
798 RESPIRATORY ARREST 8 0.0003
799 LOCALISED INFECTION 7 0.0003
800 NASAL CONGESTION 17 0.0003
801 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
802 HUNGER 4 0.0003
803 HAEMOPTYSIS 8 0.0003
804 SPEECH DISORDER 15 0.0003
805 METASTASES TO LIVER 5 0.0003
806 HALLUCINATION, VISUAL 6 0.0003
807 VISION BLURRED 39 0.0003
808 BREAST PAIN 3 0.0003
809 GALLBLADDER DISORDER 5 0.0003
810 CARDIOGENIC SHOCK 4 0.0003
811 FAECES DISCOLOURED 6 0.0003
812 LEUKOCYTOSIS 5 0.0003
813 MENTAL DISORDER 12 0.0003
814 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
815 PANIC ATTACK 10 0.0003
816 ERYTHEMA 56 0.0003
817 BLOOD GLUCOSE ABNORMAL 5 0.0003
818 PANCYTOPENIA 15 0.0003
819 BACTERIAL INFECTION 5 0.0003
820 ACUTE KIDNEY INJURY 41 0.0003
821 HAEMORRHAGE INTRACRANIAL 4 0.0003
822 MUCOSAL INFLAMMATION 7 0.0003
823 GASTRITIS 7 0.0003
824 RHABDOMYOLYSIS 11 0.0003
825 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
826 OSTEOPENIA 4 0.0003
827 MUSCULOSKELETAL DISORDER 5 0.0003
828 HERPES ZOSTER 15 0.0003
829 RESPIRATORY FAILURE 19 0.0003
830 UNDERDOSE 19 0.0003
831 TREATMENT NONCOMPLIANCE 14 0.0003
832 BLOOD PRESSURE DECREASED 17 0.0003
833 MENORRHAGIA 5 0.0003
834 TREMOR 42 0.0003
835 BACTERAEMIA 3 0.0003
836 DISORIENTATION 10 0.0003
837 PROCEDURAL PAIN 7 0.0003
838 PNEUMOTHORAX 4 0.0003
839 COMA 12 0.0003
840 BLOOD PRESSURE FLUCTUATION 6 0.0002
841 CARDIAC FAILURE 20 0.0002
842 TOXICITY TO VARIOUS AGENTS 42 0.0002
843 ADRENAL INSUFFICIENCY 3 0.0002
844 CYST 3 0.0002
845 CYTOMEGALOVIRUS INFECTION 4 0.0002
846 RASH PRURITIC 13 0.0002
847 HAEMORRHAGE 25 0.0002
848 DERMATITIS ALLERGIC 3 0.0002
849 PRODUCT QUALITY ISSUE 32 0.0002
850 PARANOIA 4 0.0002
851 THERAPEUTIC RESPONSE DECREASED 14 0.0002
852 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
853 EYE PAIN 13 0.0002
854 SWELLING FACE 15 0.0002
855 BLOOD CREATININE INCREASED 15 0.0002
856 SUICIDAL IDEATION 21 0.0002
857 EOSINOPHILIA 4 0.0002
858 TRANSAMINASES INCREASED 5 0.0002
859 TOOTH DISORDER 5 0.0002
860 HEPATOTOXICITY 5 0.0002
861 CARDIAC DISORDER 21 0.0002
862 ORAL PAIN 5 0.0002
863 RESTLESS LEGS SYNDROME 4 0.0002
864 ACUTE HEPATIC FAILURE 3 0.0002
865 RESPIRATORY DISTRESS 6 0.0002
866 APHONIA 3 0.0002
867 BLINDNESS UNILATERAL 3 0.0002
868 TARDIVE DYSKINESIA 6 0.0002
869 DRUG INEFFECTIVE 280 0.0002
870 BLOOD SODIUM DECREASED 4 0.0002
871 RENAL FAILURE ACUTE 9 0.0002
872 FOOT FRACTURE 4 0.0002
873 PROTEINURIA 4 0.0002
874 GLAUCOMA 4 0.0002
875 FLUSHING 21 0.0002
876 PRESYNCOPE 5 0.0002
877 DYSSTASIA 6 0.0002
878 PSYCHOTIC DISORDER 6 0.0002
879 OSTEONECROSIS OF JAW 5 0.0002
880 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
881 SKIN EXFOLIATION 17 0.0002
882 UPPER LIMB FRACTURE 4 0.0002
883 HOT FLUSH 15 0.0002
884 THROMBOSIS 16 0.0002
885 LACRIMATION INCREASED 6 0.0002
886 ACNE 15 0.0002
887 LYMPHADENOPATHY 7 0.0002
888 DIABETES MELLITUS 15 0.0002
889 PRODUCT ADHESION ISSUE 7 0.0002
890 RENAL DISORDER 9 0.0002
891 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
892 DISEASE RECURRENCE 9 0.0002
893 BRADYCARDIA 10 0.0002
894 INCORRECT DOSE ADMINISTERED 43 0.0002
895 ABSCESS 3 0.0002
896 FEELING ABNORMAL 45 0.0002
897 INTESTINAL OBSTRUCTION 7 0.0002
898 PAIN OF SKIN 5 0.0002
899 DISTURBANCE IN ATTENTION 10 0.0002
900 BLOOD BILIRUBIN INCREASED 5 0.0002
901 VAGINAL HAEMORRHAGE 8 0.0002
902 MOOD ALTERED 5 0.0002
903 CARDIAC ARREST 15 0.0002
904 VISUAL ACUITY REDUCED 6 0.0002
905 COAGULOPATHY 3 0.0002
906 AGITATION 13 0.0002
907 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
908 GASTRIC DISORDER 6 0.0002
909 SEIZURE 20 0.0002
910 HEART RATE DECREASED 6 0.0002
911 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
912 NEUROPATHY PERIPHERAL 16 0.0002
913 CEREBRAL HAEMORRHAGE 6 0.0002
914 DRUG ADMINISTRATION ERROR 5 0.0002
915 ABASIA 4 0.0002
916 CONJUNCTIVITIS 3 0.0002
917 GYNAECOMASTIA 5 0.0002
918 HEPATIC FUNCTION ABNORMAL 6 0.0002
919 FLATULENCE 9 0.0002
920 CARDIOVASCULAR DISORDER 4 0.0002
921 CONVULSION 9 0.0002
922 RASH GENERALISED 4 0.0002
923 PLASMA CELL MYELOMA 6 0.0002
924 OSTEONECROSIS 5 0.0002
925 LIP SWELLING 5 0.0001
926 FUNGAL INFECTION 5 0.0001
927 SKIN DISORDER 5 0.0001
928 IRRITABILITY 9 0.0001
929 FEAR 4 0.0001
930 BONE MARROW FAILURE 3 0.0001
931 INTERSTITIAL LUNG DISEASE 7 0.0001
932 NEOPLASM PROGRESSION 5 0.0001
933 DISEASE PROGRESSION 17 0.0001
934 BLOOD GLUCOSE INCREASED 27 0.0001
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
936 THROAT IRRITATION 6 0.0001
937 BLOOD POTASSIUM DECREASED 4 0.0001
938 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
939 EMOTIONAL DISORDER 4 0.0001
940 RENAL FAILURE 17 0.0001
941 BONE DENSITY DECREASED 4 0.0001
942 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
943 EYE DISORDER 4 0.0001
944 STAPHYLOCOCCAL INFECTION 4 0.0001
945 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
946 MYOCARDIAL INFARCTION 21 0.0001
947 AGEUSIA 3 0.0001
948 ANGER 4 0.0001
949 BREAST CANCER 11 0.0001
950 ANAPHYLACTIC SHOCK 3 0.0001
951 DEVICE DISLOCATION 5 0.0001
952 CARDIAC FAILURE CONGESTIVE 9 0.0001
953 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
954 MYELOSUPPRESSION 4 0.0001
955 DRUG EFFECT INCOMPLETE 4 0.0001
956 EMOTIONAL DISTRESS 13 0.0001
957 OCULAR HYPERAEMIA 5 0.0001
958 HOSPITALISATION 16 0.0001
959 SURGERY 6 0.0001
960 INJECTION SITE HAEMORRHAGE 8 0.0001
961 DEVICE BREAKAGE 4 0.0001
962 BLINDNESS 4 0.0001
963 UNEVALUABLE EVENT 7 0.0001
964 PRODUCT DOSE OMISSION 6 0.0001
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
966 NEOPLASM MALIGNANT 6 0.0001
967 PRODUCT DOSE OMISSION ISSUE 26 0.0001
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
969 BLOOD GLUCOSE DECREASED 4 0.0001
970 CRYING 3 0.0001
971 DRUG WITHDRAWAL SYNDROME 7 0.0001
972 DEATH 66 0.0001
973 NERVOUSNESS 4 0.0001
974 INJECTION SITE BRUISING 6 0.0001
975 DRY SKIN 10 0.0001
976 PROSTATE CANCER 6 0.0001
977 DRUG EFFECT DECREASED 4 0.0001
978 DRUG DOSE OMISSION 12 0.0001
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
980 EYE IRRITATION 4 0.0001
981 DEVICE LEAKAGE 3 0.0001
982 ILLNESS 7 0.0001
983 INJECTION SITE SWELLING 5 0.0001
984 SKIN BURNING SENSATION 4 0.0001
985 DEVICE ISSUE 5 0.0001
986 INJECTION SITE PAIN 17 0.0001
987 NO ADVERSE EVENT 9 0.0000
988 DEVICE MALFUNCTION 3 0.0000
989 COMPLETED SUICIDE 3 0.0000
990 INJECTION SITE ERYTHEMA 4 0.0000
991 DRUG DEPENDENCE 4 0.0000